| Primary information |
|---|
| sequence ID | Seq_2448 |
| Peptide sequence | FVELGTQPATQ |
| CancerPDF_ID | CancerPDF_ID758, CancerPDF_ID5059, CancerPDF_ID8855, |
| PMID | 19795908,24982608,24694173 |
| Protein Name | Apolipoprotein A-II,Apolipoprotein A-II,Apolipoprotein A-II |
| UniprotKB Entry Name | APOA2_HUMAN,APOA2_HUMAN,APOA2_HUMAN |
| Fluid | Plasma,Urine,Ascites fluid |
| M/Z | 595.8,NA,NA |
| Charge | 2,NA,1 |
| Mass (in Da) | NA,NA,NA |
| fdr | NA,NA,NA |
| Profiling Technique | LC-MS,Nano-LC-MS,LTQ-Orbitrap XL |
| Peptide Identification technique | MALDI-TOF/TOF,MS/MS,X tandem for peptide identification |
| Quantification Technique | LC-MRM (multiple reaction monitoring),NA,NA |
| Labelled/Label Free | Labelled,Label Free,Label Free |
| FDR | less than 7%,0.01,NA |
| CancerPDF_ID | CancerPDF_ID758, CancerPDF_ID5059, CancerPDF_ID8855, |
| p-Value | NA,NA,NA |
| Software | FlexAnalysis 3.0 and Biotools 3.0 software,"GPM search engine, MASCOT","X tandem for peptide identification,Scaffold 2 software for any modification analysis" |
| Length | 11,11,11 |
| Cancer Type | Ductal adenocarcinoma of the pancreas (DAP),Ovarian cancer,Ovarian cancer |
| Database | NCBI refseq Protein Database,IPI 3.71 Human Database ,IPI00021854 |
| Modification | NA,NA,NA |
| Number of Patients | "36 normal, 23 patients",6 Ovarian cancer patients and 6 normal individuals,3 ovarian cancer patient and 3 non cancerous control |
| Regulation | NA,Uniquely present in case of urine of ovarian cancer patients,Uniquely expressed in ovarian cancer patient |
| Validation | NA,NA,NA |
| Sensitivity | NA,NA,NA |
| Specificity | NA,NA,NA |
| Accuracy | NA,NA,NA |
| Peptide Atlas | PeptideAtlas |
| IEDB | |